MARCO and cancer: Intriguingly, antibody-mediated depletion of MARCO inhibits cancer progression and metastasis, enhancing ICB efficacy (60), suggesting that SPP1+ macrophages play a non-negligible role in the immunorepressive response and immunotherapeutic resistance.